Risk of myeloid neoplasms after solid organ transplantation

Solid organ transplant recipients have elevated cancer risks, due in part to pharmacologic immunosuppression. However, little is known about risks for hematologic malignancies of myeloid origin. We linked the US Scientific Registry of Transplant Recipients with 15 population-based cancer registries...

Full description

Bibliographic Details
Main Authors: Morton, Lindsay M., Gibson, Todd M., Clarke, Christina A., Lynch, Charles F., Anderson, Lesley A., Pfeiffer, Ruth, Landgren, Ola, Weisenburger, Dennis D., Engels, Eric A.
Format: Online
Language:English
Published: 2014
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4197126/